Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The nucleus pulposus is the gelatinous inner core of the intervertebral disc, surrounded by the annulus fibrosus and flanked by cartilage endplates[1][6][10]. It is composed mainly of water, proteoglycans (notably aggrecan), and collagen type II[3][6][9]. Its primary function is to absorb and distribute forces—to act as a shock absorber and allow motion in the vertebral column[4][7]. With aging and degeneration, the NP loses water and proteoglycan content, altering its mechanical properties and contributing to spine disorders such as degenerative disc disease and back pain[2][3][8]. The NP is not a single molecule or gene, but a complex, distinct tissue region with a specialized cell population, relevant primarily in anatomical, orthopedic, and tissue engineering contexts rather than traditional drug targeting[1][10].
Not applicable (not a molecular target for drugs)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nucleus pulposus of intervertebral disc (NP).